When a patient with breast cancer had more than the usual amount of toxic effects from the chemotherapy regimen she was on, Hardeep Phull, MD, an oncologist with the Sharp Rees-Stealy Medical Group in San Diego, was puzzled.
“It’s normal to have some side effects, but she was extremely tired, and the more tired she got, the more supplements she took, thinking it would boost her energy. When I noticed she drank what looked like a milkshake, I asked her what’s in it, and turns out it was milk with turmeric, and she had two bottles of it a day with lots of turmeric,” Phull said.
This article highlights the scope for developing therapeutics with new innovative, alternative approaches. The current trillion dollars pharmaceutical industry is in peril where the current drug development pipeline is slow, inefficient and incapable of being extended to multi-combination drug therapies as well as minimally focused on prevention. The complex modeling of diseases and biological functions has been limited because of the inability to integrate large scale molecular pathways.
Watch this Video to understand how recent advances provide breakthrough technology for doing scalable modeling of complex molecular systems to dramatically accelerate drug discovery and development.